Expression of Bioactive Thymosin Alpha 1 (Tα1) in Marker-free Transgenic Lettuce (Lactuca sativa)

Plant Molecular Biology Reporter

Volumn 29, Issue 2, 2011, Pages 466-472

  Cui, Lijie ^a   Chen, Yuhui ^a   Shen, Guoan ^a   Zhao, Lingxia ^a   Tang, Kexuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Bioactive; Marker free; Thymosin alpha 1; Transgenic lettuce

Indexed keywords

AGROBACTERIUM; LACTUCA; LACTUCA SATIVA; RHIZOBIUM;

EID: 79953026460     PISSN: 07359640     EISSN: 15729818     Source Type: Journal    
DOI: 10.1007/s11105-010-0246-5     Document Type: Article

References (42)

1. Basaran P, Rodríguez-Cerezo E (2008) Plant molecular farming: opportunities and challenges. Crit Rev Biotechnol 28: 153-172.
2. Billich A (2002) Thymosin alpha1. SciClone Pharmaceuticals. Curr Opin Investig Drugs 3: 698-707.
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
4. Brodzik R, Glogowska M, Bandurska K, Okulicz M, Deka D, Ko K et al (2006) Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells. Proc Natl Acad Sci USA 103: 8804-8809.
5. Chen PF, Zhang HY, Fu GF, Xu GX, Hou YY (2005) Overexpression of soluble human thymosin alpha 1 in Escherichia coli. Acta Biochim Biophys Sin (Shanghai) 37: 147-151.
6. Chen YH, Wang AX, Zhao LX, Shen GA, Cui LJ, Tang KX (2009) Expression of thymosin alpha1 concatemer in transgenic tomato (Solanum lycopersicum) fruits. Biotechnol Appl Biochem 52: 303-312.
7. Chupeau MC, Bellini C, Guerche P, Maisonneuve B, Vastra G, Chupeau Y (1989) Transgenic plants of lettuce Lactuca sativa obtained through electroporation of protoplasts. Biotechnology 7: 503-508.
8. Ciancio A, Rizzetto M (2010) Thymalfasin in the treatment of hepatitis B and C. Ann NY Acad Sci 1194: 141-146.
9. Cleri DJ, Ricketti AJ, Vernaleo JR (2007) Fever of unknown origin due to zoonoses. Infect Dis Clin North Am 21: 963-996.
10. Cox KM, Sterling JD, Regan JT, Gasdaska JR, Frantz KK, Peele CG et al (2006) Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat Biotechnol 24: 1591-1597.
11. Daley M, Knauf VC, Summerfelt KR, Turner JC (1998) Co-transformation with one Agrobacterium tumefaciens strain containing two binary plasmids as a method for producing marker-free transgenic plants. Plant Cell Rep 17: 489-496.
12. Daniell H, Streatfield SJ, Wycoff K (2001) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci 6: 219-226.
13. De Framond AJ, Back EW, Chilton WS, Kayes L, Chilton M (1986) Two unlinked T-DNAs can transform the same tobacco plant cell and segregate in the F1 generation. Mol Gen Genet 202: 125-131.
14. Depicker A, Herman L, Jacobs A, Schell J, van Montagu M (1985) Frequencies of simultaneous transformation with different T-DNAs and their relevance to Agrobacterium/plant cell interaction. Mol Gen Genet 201: 477-484.
15. Fischer R, Emans N (2000) Molecular farming of pharmaceutical proteins. Transgenic Res 9: 279-299.
16. Fischer R, Twyman RM, Schillberg S (2003) Production of antibodies in plants and their use for global health. Vaccine 21: 820-825.
17. Fischer R, Stoger E, Schillberg S, Christou P, Twyman RM (2004) Plant based production of biopharmaceuticals. Curr Opin Plant Biol 7: 152-158.
18. Garaci E, Favalli C, Pica F, Sinibaldi VP, Palamara AT, Matteucci C et al (2007) Thymosin alpha 1: from bench to beside. Ann NY Acad Sci 1112: 225-234.
19. Goldstein AL, Goldstein AL (2009) From lab to bedside: emerging clinical applications of thymosin alpha 1. Expert Opin Biol Ther 9: 593-608.
20. Goldstein AL, Low TL, McAdoo M, McClure J, Thurman GB, Rossio J et al (1977) Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide. Proc Natl Acad Sci USA 74: 725-729.
21. Hadden JW (2001) Aspects of the immunopharmacology of thymosin Tα1. Clin Appl Immunol Rev 1: 187-191.
22. Horn ME, Woodard SL, Howard JA (2004) Plant molecular farming: systems and products. Plant Cell Rep 22: 711-720.
23. Hull AK, Criscuolo CJ, Mett V, Groen H, Steeman W, Westra H et al (2005) Human-derived, plant-produced monoclonal antibody for the treatment of anthrax. Vaccine 23: 2082-2086.
24. Joshi L, Lopez LC (2005) Bioprospecting in plants for engineered proteins. Curr Opin Plant Biol 8: 223-226.
25. Komari T, Hiei Y, Saito Y, Murai N, Kumashiro T (1996) Vectors carrying two separate T-DNAs for co-transformation of higher plants mediated by Agrobacterium tumefaciens and segregation of transformants free from selection markers. Plant J 10: 165-174.
26. Lico C, Chen Q, Santi L (2008) Viral vectors for production of recombinant proteins in plants. J Cell Physiol 216: 366-377.
27. Liénard D, Sourrouille C, Gomord V, Faye L (2007) Pharming and transgenic plants. Biotechnol Annu Rev 13: 115-147.
28. Ma JKC, Drake PMW, Christou P (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4: 794-805.
29. Marx J (2007) Behavioral genetics. Evidence linking DISC1 gene to mental illness builds. Science 316: 682-683.
30. McCabe MS, Garratt LC, Schepers F, Jordi WJ, Stoopen GM, Davelaar E et al (2001) Effects of P(SAG12)-IPT gene expression on development and senescence in transgenic lettuce. Plant Physiol 127: 505-516.
31. Michelmore RW, Marsh E, Seeley S, Landry BS (1987) Transformation of lettuce mediated by Agrobacterium tumefaciens. Plant Cell Rep 6: 439-442.
32. Moscarella S, Buzzelli G, Romanelli RG, Monti M, Giannini C, Careccia G et al (1998) Interferon and thymosin combination therapy in naïve patients with chronic hepatitis C: preliminary results. Liver 18: 366-369.
33. Naylor PH, Hadden JW (2010) Preclinical studies with IRX-2 and thymosin α1 in combination therapy. Ann NY Acad Sci 1194: 162-168.
34. Okubara PA, Arroyo-Garcia R, Shen KA, Mazier M, Meyers BC, Ochoa OE et al (1997) A transgenic mutant of Lactuca sativa (lettuce) with a T-DNA tightly linked to loss of downy mildew resistance. Mol Plant Microb Interact 10: 970-977.
35. Ramessar K, Rademacher T, Sack M, Stadlmann J, Platis D, Stiegler G et al (2008) Cost-effective production of a vaginal protein microbicide to prevent HIV transmission. Proc Natl Acad Sci USA 105: 3727-3732.
36. Schillberg S, Twyman RM, Fischer R (2005) Opportunities for recombinant antigen and antibody expression in transgenic plants-technology assessment. Vaccine 23: 1764-1769.
37. Stewart CN, Via LE (1993) A rapid CTAB DNA isolation technique useful for RAPD fingerprinting and other PCR applications. Biotechniques 14: 748-749.
38. Streatfield SJ (2007) Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol J 5: 2-15.
39. Twyman RM, Stoger E, Schillberg S, Christou P, Fischer R (2003) Molecular farming in plants: host systems and expression technology. Trends Biotechnol 21: 570-578.
40. Wang SW, Stevenson AL, Kearsey SE, Watt S, Bähler J (2008) Global role for polyadenylation-assisted nuclear RNA degradation in posttranscriptional gene silencing. Mol Cell Biol 28: 656-665.
41. Weigel D, Glazebrook J (2006) Cold Spring Harb. Protoc. doi: 10. 1101/pdb. prot4666.
42. Zavaglia C, Severini R, Tinelli C, Franzone JS, Airoldi A, Tempini S et al (2000) A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B. Dig Dis Sci 45: 690-696.